ISRG
Intuitive Surgical Inc
$
444.550
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
447.130
Open
438.120
VWAP
442.28
Vol
2.65M
Mkt Cap
159.36B
Low
433.810
Amount
1.17B
EV/EBITDA(TTM)
47.14
Total Shares
354.71M
EV
151.93B
EV/OCF(TTM)
53.76
P/S(TTM)
17.45
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
2.59B
+14.95%
2.053
+13.42%
2.69B
+11.37%
2.174
-1.62%
2.41B
+18.13%
1.993
+8.3%
Estimates Revision
The market is revising Upward the revenue expectations for Intuitive Surgical, Inc. (ISRG) for FY2025, with the revenue forecasts being adjusted by 1.31% over the past three months. During the same period, the stock price has changed by -13.69%.
Revenue Estimates for FY2025
Revise Upward
+1.31%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+3.93%
In Past 3 Month
Stock Price
Go Down
-13.69%
In Past 3 Month
21 Analyst Rating
35.18% Upside
Wall Street analysts forecast ISRG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISRG is 600.94 USD with a low forecast of 440.00 USD and a high forecast of 685.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Buy
4 Hold
1 Sell
Moderate Buy
35.18% Upside
Current: 444.550
Low
440.00
Averages
600.94
High
685.00
35.18% Upside
Current: 444.550
Low
440.00
Averages
600.94
High
685.00
Deutsche Bank
Sell
maintain
$440
2025-08-22
Reason
Deutsche Bank
Price Target
$440
2025-08-22
maintain
Sell
Reason
Deutsche Bank says the firm's channel checks suggest "broad and growing interest" in cheaper remanufactured instruments at robotics programs. Intuitive's instruments and accessories franchise, which represents 60% of its total sales, are at risk by remanufactured da Vinci instruments over the next few years, the analyst tells investors in a research note. Deutsche expects "significant and growing engagement" with remanufacturers by larger hospital systems. It keeps a Sell rating on Intuitive Surgical shares with a $440 price target.
Leerink
Outperform
maintain
$593
2025-08-19
Reason
Leerink
Price Target
$593
2025-08-19
maintain
Outperform
Reason
Leerink believes the post-earnings selloff in Intuitive Surgical shares creates an attractive buying opportunity. The firm believes the Street is getting the story wrong and that the pullback does not reflect the strength of the company's underlying fundamentals. The U.S. DV5 launch suggests potentially underappreciated outside the U.S. acceleration in the second half of 2026, the analyst tells investors in a research note. Leerink reiterates an Outperform rating on Intuitive Surgical with a $593 price target.
Baird
Outperform
maintain
$590 -> $605
2025-07-23
Reason
Baird
Price Target
$590 -> $605
2025-07-23
maintain
Outperform
Reason
Baird raised the firm's price target on Intuitive Surgical to $605 from $590 and keeps an Outperform rating on the shares. The firm is surprised by the limited share rally post earnings last night, saying Intuitive posted its highest operating margin in the last 15 quarters on top of a Q2 that brought "stellar" revenue and earnings growth. Baird remains a buyer of the stock. The company's key performance indicators "continue to fire on all cylinders," the firm contends.
Wells Fargo
Larry Biegelsen
Overweight
maintain
$559 -> $599
2025-07-23
Reason
Wells Fargo
Larry Biegelsen
Price Target
$559 -> $599
2025-07-23
maintain
Overweight
Reason
Wells Fargo analyst Larry Biegelsen raised the firm's price target on Intuitive Surgical to $599 from $559 and keeps an Overweight rating on the shares. The firm notes Q2 revenues and EPS came in above consensus, driven by strength across the board. The company reported Q2 procedure growth of about 17% and 2025 procedure growth guidance was raised from 15%-17% to 15.5%-17%, Wells adds.
Piper Sandler
Adam Maeder
Overweight
maintain
$575 -> $595
2025-07-23
Reason
Piper Sandler
Adam Maeder
Price Target
$575 -> $595
2025-07-23
maintain
Overweight
Reason
Piper Sandler analyst Adam Maeder raised the firm's price target on Intuitive Surgical to $595 from $575 and keeps an Overweight rating on the shares. The firm reported a strong Q2 ahead of consensus on both the top and bottom line. Additionally, management raised its 2025 procedure guidance from +15%-17% year-over-year to +15.5%-17%, which Piper believes leaves room for further upside to materialize this year.
BTIG
Buy
maintain
$566 -> $571
2025-07-23
Reason
BTIG
Price Target
$566 -> $571
2025-07-23
maintain
Buy
Reason
BTIG raised the firm's price target on Intuitive Surgical to $571 from $566 and keeps a Buy rating on the shares following the Q2 results. Despite the second quarter in a row where placements fell short of expectations, System average selling prices remain strong, coupled with new geographic market expansion, and healthy procedure demand, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Intuitive Surgical Inc (ISRG.O) is 51.25, compared to its 5-year average forward P/E of 57.32. For a more detailed relative valuation and DCF analysis to assess Intuitive Surgical Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
57.32
Current PE
51.25
Overvalued PE
66.86
Undervalued PE
47.79
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
38.70
Current EV/EBITDA
34.72
Overvalued EV/EBITDA
45.76
Undervalued EV/EBITDA
31.63
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
16.49
Current PS
15.05
Overvalued PS
19.53
Undervalued PS
13.45
Financials
Annual
Quarterly
FY2025Q2
YoY :
+21.40%
2.44B
Total Revenue
FY2025Q2
YoY :
+31.27%
745.60M
Operating Profit
FY2025Q2
YoY :
+24.97%
664.20M
Net Income after Tax
FY2025Q2
YoY :
+23.97%
1.81
EPS - Diluted
FY2025Q2
YoY :
+80.04%
560.10M
Free Cash Flow
FY2025Q2
YoY :
-2.91%
66.31
Gross Profit Margin - %
FY2025Q2
YoY :
+293.68%
21.81
FCF Margin - %
FY2025Q2
YoY :
+2.95%
27.22
Net Margin - %
FY2025Q2
YoY :
+1.73%
15.92
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.8M
USD
5
3-6
Months
10.3M
USD
18
6-9
Months
35.1M
USD
21
0-12
Months
29.5M
USD
19
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
812.5K
Volume
18
6-9
Months
853.7K
Volume
25
0-12
Months
0.0
Volume
0
Bought
0-3
1
671.0
Volume
Months
3-6
12
644.5K
Volume
Months
6-9
17
291.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areSelling! The selling amount has increased100%over the last month.
Sold
0-3
Months
16.0K
USD
2
3-6
Months
145.5K
USD
9
6-9
Months
48.0K
USD
6
0-12
Months
8.0K
USD
1
Bought
0-3
1
8.0K
USD
Months
3-6
1
32.5K
USD
Months
6-9
4
32.0K
USD
Months
0-12
1
8.0K
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.8M
USD
5
3-6
Months
10.3M
USD
18
6-9
Months
35.1M
USD
21
0-12
Months
29.5M
USD
19
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ISRG News & Events
Events Timeline
2025-09-12 (ET)
2025-09-12
09:17:22
Intuitive Surgical Launches Real-Time Surgical Insights for da Vinci 5
2025-09-09 (ET)
2025-09-09
11:04:13
MemorialCare Introduces da Vinci 5 System at Three Locations, According to Intuitive Surgical
2025-09-03 (ET)
2025-09-03
13:22:00
Intuitive Surgical projects a gross margin of approximately 66% for FY25.
Sign Up For More Events
Sign Up For More Events
News
8.0
09-18NASDAQ.COMSignificant Options Trading on Thursday: AWI, METC, ISRG
2.0
09-18TipRanksQQQ ETF Update, September 18, 2025
8.0
09-17NASDAQ.COMISRG Options for February 2026 Now Available for Trading
Sign Up For More News
People Also Watch
NVS
Novartis AG
123.360
USD
+0.35%
SHEL
Shell PLC
71.050
USD
+0.37%
LIN
Linde PLC
477.760
USD
-0.26%
QCOM
Qualcomm Inc
169.720
USD
+1.72%
ABT
Abbott Laboratories
136.620
USD
+0.43%
TXN
Texas Instruments Inc
179.620
USD
+0.14%
CAT
Caterpillar Inc
472.100
USD
+1.19%
VZ
Verizon Communications Inc
43.160
USD
-0.74%
GE
General Electric Co
301.020
USD
-0.04%
RY
Royal Bank of Canada
148.600
USD
+0.91%
FAQ
What is Intuitive Surgical Inc (ISRG) stock price today?
The current price of ISRG is 444.55 USD — it has increased 1.33 % in the last trading day.
What is Intuitive Surgical Inc (ISRG)'s business?
What is the price predicton of ISRG Stock?
What is Intuitive Surgical Inc (ISRG)'s revenue for the last quarter?
What is Intuitive Surgical Inc (ISRG)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Intuitive Surgical Inc (ISRG)'s fundamentals?
How many employees does Intuitive Surgical Inc (ISRG). have?